Format

Send to

Choose Destination
Leukemia. 2020 Jan 7. doi: 10.1038/s41375-019-0701-8. [Epub ahead of print]

Rare germline variant contributions to myeloid malignancy susceptibility.

Author information

1
Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
2
Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
3
Myelodysplastic Syndrome Research Group, Josep Carreras Leukaemia Research Institute, Institut CatalĂ  d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
4
Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA. thomas.laframboise@case.edu.
PMID:
31911633
DOI:
10.1038/s41375-019-0701-8

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center